GFAP and Alzheimer disease: Specifically, elevated pulse pressure showed a consistently negative relationship with brain health evidenced across several key biomarkers (pTau181, NfL, GFAP), while elevated systolic blood pressure only associated with a marker of increased AD pathobiology (pTau181).